DSM-Firmenich stock rises 3.68 percent near its EUR 103.75 high
Published on 10/13/2026 at 14:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
DSM-Firmenich stock (ISIN CH1216478797) rose 3.68 percent to EUR 103.33 at Lang & Schwarz on October 13, 2026 at 2:16 p.m. CEST, placing the price 0.40 percent below its EUR 103.75 52-week high. Finanz und Wirtschaft identifies the company as DSM Firmenich, ticker DSFIR, listed on the SIX Swiss Exchange.
First-half revenue reaches EUR 4.66 billion
De Belegger reported that revenue from continuing operations reached EUR 4.66 billion in the first half of 2026, with like-for-like growth of 5 percent. Adjusted earnings before interest, taxes, depreciation and amortization came to EUR 900 million, compared with EUR 906 million in the first half of 2025, while the reported margin was 19.30 percent.
The mix matters for the valuation. Perfumery & Beauty generated EUR 424 million of adjusted earnings before interest, taxes, depreciation and amortization in the first half of 2026, ahead of Taste, Texture & Health at EUR 321 million and Health, Nutrition & Care at EUR 206 million.
Price stays near the yearly high
The Lang & Schwarz price is EUR 0.42 below the 52-week high of EUR 103.75, equivalent to a 0.40 percent gap. The current price is also EUR 3.67 above the Euronext close of October 12, 2026, which was EUR 99.66. That comparison gives the move a clear market dimension without relying on the Swiss franc quotation.
The valuation frame is mixed. Market capitalization was EUR 25.5 billion, while the trailing P/E was negative 21.43. On October 2, BNP Paribas analyst Nicola Tang downgraded DSM-Firmenich to Neutral from Outperform and set a EUR 100.00 target, Markets Insider reported. The target is 3.22 percent below the Lang & Schwarz price.
Comparison with peers on October 13, 2026
DSM-Firmenich (SIX, EUR): plus 3.68 percent, P/E minus 21.43, market capitalization EUR 25.5 billion
Givaudan (SIX, CHF): plus 8.20 percent, P/E 28.04, market capitalization CHF 34.8 billion
Symrise (Xetra, EUR): plus 3.11 percent, P/E 36.11, market capitalization EUR 13.2 billion
DSM-Firmenich price at Lang & Schwarz
DSM-Firmenich stock was trading at EUR 103.33 at Lang & Schwarz on October 13, 2026 at 2:16 p.m. CEST, 3.68 percent above the Euronext close of October 12, 2026 at EUR 99.66. The further course of trading is shown by the continuously updated real-time quote of DSM-Firmenich stock.
DSM-Firmenich market data
- Company: dsm-firmenich AG
- ISIN: CH1216478797
- Ticker: DSFIR
- Primary exchange: SIX Swiss Exchange
- Price Lang & Schwarz (as of October 13, 2026, 2:16 p.m. CEST): EUR 103.33
- Change versus Euronext close (October 12, 2026): plus 3.68 percent
- Euronext close (October 12, 2026): EUR 99.66
- Market capitalization: EUR 25.5 billion (as of October 13, 2026)
- 52-week range: EUR 55.22-103.75 (as of October 13, 2026)
- Sector / Industry: Basic Materials / Specialty Chemicals
Market context: Market report SMI.
